List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 431 studies with search of: "Carcinoma, Hepatocellular"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma;   Metastatic Hepatocellular Carcinoma
Intervention: Drug: Sorafenib with Capecitabine and Oxaliplatin
2 Recruiting A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Genetic: JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
3 Not yet recruiting Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: epirubicin;   Drug: Cisplatin
4 Recruiting Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Transarterial Chemoembolization;   Radiation: Proton Beam Radiotherapy
5 Recruiting Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma
Conditions: Hepatitis B;   Carcinoma, Hepatocellular;   Polymorphism, Genetic
Intervention:
6 Terminated Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: percutaneous ablation of hepatocellular carcinoma
7 Recruiting Trial for Hepatocellular Carcinoma Related Viral Hepatitis Adjuvant Treatment
Conditions: Carcinoma, Hepatocellular;   Hepatitis, Viral, Human
Intervention: Drug: 131 I-lipiodol
8 Completed A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.
Condition: Carcinoma, Hepatocellular
Intervention: Biological: GV1001
9 Active, not recruiting Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: percutaneous ethanol instillation (PEI)
10 Recruiting SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Hepatoma
Intervention: Device: SIR-Spheres microspheres
11 Completed
Has Results 		A Study to Estimate Safety and Efficacy of Bay 43-9006 in the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Nexavar (Sorafenib, BAY43-9006)
12 Completed
Has Results 		A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin;   Drug: Doxorubicin/Placebo
13 Completed Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Somatostatin (octreotide)
14 Recruiting Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
15 Recruiting Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Thalidomide(Thado)
16 Completed Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Capecitabine in HCC
17 Completed Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
Conditions: Carcinoma, Hepatocellular;   Liver Neoplasms
Interventions: Procedure: Photodynamic therapy;   Drug: Talaporfin Sodium
18 Active, not recruiting A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
Conditions: Carcinoma, Hepatocellular;   Liver Neoplasms
Interventions: Drug: Talaporfin sodium;   Device: Interstitial Light Emitting Diodes;   Procedure: Percutaneous placement of device in the liver;   Procedure: Standard Care
19 Active, not recruiting Phase II Study of Best Support Care (BSC) Plus ZD6474 in Patients With Inoperable Hepatocellular Carcinoma (HCC)
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Vandetanib;   Drug: Best Supportive Care
20 Recruiting Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib and Gemcitabine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services